Search

everythinglearnresearchcommunity

for

Search:↓

Using both minoxidil and finasteride together is more effective for hair growth than using either one alone in men with hair loss.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Cyproterone acetate is an effective treatment for women with acne, hair loss, and excessive hair growth.

The FDA did not approve a testosterone drug because of safety concerns.

The methods accurately measured brain androgens, showing most 5α-androstane-3α,17β-diol comes from outside the brain, while androsterone is both transported and made in the brain.

Injections of special skin cells showed potential in treating hair loss, with some participants experiencing increased hair density.

A new treatment for hair loss was tested and most participants saw their hair loss stop within 2-8 weeks, with up to 50% more hair after 4 months, and no side effects.

Scientists made all eight versions of a compound called cyoctol, but found it's not an anti-androgen and it fully breaks down in the skin.

Intramuscular cyproterone acetate effectively treats hirsutism and improves skin conditions in women with hyperandrogenism.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

New treatment improves male hair loss.

PSA screening's effectiveness in reducing prostate cancer deaths can vary based on trial design and participant compliance.

Dihydrotestosterone gel before hypospadias surgery led to less scarring but raised concerns about potential psychological effects and skin changes.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

Finasteride and dutasteride effectively reduce DHT in hair, which may help evaluate their treatment success for hair loss.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

Clinical signs of excess male hormones and actual hormone levels in the blood do not always match in women with polycystic ovary syndrome.

A man developed alopecia areata after starting cancer treatment with vandetanib.

Cyclosporine showed some improvement in alopecia areata but results were not statistically significant.

Men with early balding may have a higher risk of prostate issues, and surgery for prostate cancer has a slight survival benefit over radiation.

The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.